ARCHIVES

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

This article is from The Cancer Letter archive.

Vol. 12 No. 13 | March 28, 1986

Download PDF Visit The Full Archive

Related Articles

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

In Brief: Cancer Center Founder In Bosnia Seeks Attention From Colleagues: Phone Calls Will Help, He Says

January 22, 1993

With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA

August 2, 2013

In Brief: NIH Alumni Assn. Formed; Jenney Named Kans. Vice Chancellor; Bloomfield To Move To RPMI

June 9, 1989

Consensus Conference Planned On Adjuvant Chemotherapy For Breast Cancer

March 22, 1985